Virtu Financial’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Virtu Financial’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25,140	Closed	-$1.03M	–	2068
2024 Q2	$1.03M	Buy	+25,140	New	+$1.05M	0.07%	289
2024 Q1	–	Sell	-5,803	Closed	-$246K	–	2309
2023 Q4	$246K	Buy	+5,803	New	+$167K	0.02%	703
2023 Q3	–	Sell	-14,053	Closed	-$447K	–	2070
2023 Q2	$447K	Buy	+14,053	New	+$431K	0.03%	436
2021 Q4	–	Sell	-8,525	Closed	-$251K	–	2283
2021 Q3	$251K	Buy	+8,525	New	+$239K	0.02%	801
2021 Q1	–	Sell	-15,478	Closed	-$257K	–	2138
2020 Q4	$257K	Buy	+15,478	New	+$201K	0.03%	721

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Virtu Financial's CERE Position: Q3 2024 in Review

Virtu Financial sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 25,140 shares — an estimated $1.03M sold.

Virtu Financial first reported a position in CERE in Q4 2020 and held it in 5 quarters. The position peaked at $1.03M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Virtu Financial reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Virtu Financial sold 25,140 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.03M.
Virtu Financial first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Virtu Financial's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.03M in Q2 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.